Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunling Hu

Showing results (101-110 of 133) with videos related to

Pageof 14
Sort By:
JAMA Oncology|February 17, 2022
Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling AnalysisKathryn P Lowry, H Amarens Geuzinge, Natasha K Stout, et al.
JCO Precision Oncology|August 25, 2020
Pathogenic Variants in Cancer Predisposition Genes and Prostate Cancer Risk in Men of African AncestryMarco Matejcic, Yesha Patel, Jenna Lilyquist, et al.
NPJ Breast Cancer|November 10, 2017
Erratum: Author Correction: The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer riskThomas P Slavin, Kara N Maxwell, Jenna Lilyquist, et al.
NPJ Breast Cancer|June 27, 2017
The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer riskThomas P Slavin, Kara N Maxwell, Jenna Lilyquist, et al.
Journal of the National Cancer Institute|August 13, 2018
Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel TestingHermela Shimelis, Holly LaDuca, Chunling Hu, et al.
American Journal of Human Genetics|February 28, 2024
Functional analysis and clinical classification of 462 germline BRCA2 missense variants affecting the DNA binding domainChunling Hu, Huaizhi Huang, Jie Na, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2020
Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast CancerSiddhartha Yadav, Chunling Hu, Steven N Hart, et al.
JCO Precision Oncology|September 21, 2020
Mutation Rates in Cancer Susceptibility Genes in Patients With Breast Cancer With Multiple Primary CancersKara N Maxwell, Brandon M Wenz, Abha Kulkarni, et al.
Blood|January 28, 2021
Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repairJithma P Abeykoon, Xiaosheng Wu, Kevin E Nowakowski, et al.
Cancer Research|November 23, 2016
Transcriptional Induction of Periostin by a Sulfatase 2-TGFβ1-SMAD Signaling Axis Mediates Tumor Angiogenesis in Hepatocellular CarcinomaGang Chen, Ikuo Nakamura, Renumathy Dhanasekaran, et al.
Pageof 14

Showing results (101-110 of 133) with videos related to

Sort By:
Pageof 14
JAMA Oncology|February 17, 2022
Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling AnalysisKathryn P Lowry, H Amarens Geuzinge, Natasha K Stout, et al.
JCO Precision Oncology|August 25, 2020
Pathogenic Variants in Cancer Predisposition Genes and Prostate Cancer Risk in Men of African AncestryMarco Matejcic, Yesha Patel, Jenna Lilyquist, et al.
NPJ Breast Cancer|November 10, 2017
Erratum: Author Correction: The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer riskThomas P Slavin, Kara N Maxwell, Jenna Lilyquist, et al.
NPJ Breast Cancer|June 27, 2017
The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer riskThomas P Slavin, Kara N Maxwell, Jenna Lilyquist, et al.
Journal of the National Cancer Institute|August 13, 2018
Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel TestingHermela Shimelis, Holly LaDuca, Chunling Hu, et al.
American Journal of Human Genetics|February 28, 2024
Functional analysis and clinical classification of 462 germline BRCA2 missense variants affecting the DNA binding domainChunling Hu, Huaizhi Huang, Jie Na, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2020
Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast CancerSiddhartha Yadav, Chunling Hu, Steven N Hart, et al.
JCO Precision Oncology|September 21, 2020
Mutation Rates in Cancer Susceptibility Genes in Patients With Breast Cancer With Multiple Primary CancersKara N Maxwell, Brandon M Wenz, Abha Kulkarni, et al.
Blood|January 28, 2021
Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repairJithma P Abeykoon, Xiaosheng Wu, Kevin E Nowakowski, et al.
Cancer Research|November 23, 2016
Transcriptional Induction of Periostin by a Sulfatase 2-TGFβ1-SMAD Signaling Axis Mediates Tumor Angiogenesis in Hepatocellular CarcinomaGang Chen, Ikuo Nakamura, Renumathy Dhanasekaran, et al.
Pageof 14